Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study Meeting Abstract
| Authors: | Rosenberg, J. E.; Bono, P.; Kim, J.; Spiliopoulou, P.; Calvo, E.; Pillai, R.; Ott, P. A.; de Braud, F.; Morse, M.; Le, D.; Jaeger, D.; Chan, E.; Harbison, C.; Lin, C. S.; Tschaika, M.; Azrilevich, A.; Sharma, P. |
| Abstract Title: | Nivolumab monotherapy in metastatic urothelial cancer (mUC): Updated efficacy by subgroups and safety results from the CheckMate 032 study |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi271 |
| Language: | English |
| ACCESSION: | WOS:000393912500780 |
| DOI: | 10.1093/annonc/mdw373.12 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 784P -- Source: Wos |
